arrow

University of Colorado System
H指数:0
被引数:223

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trial

奥马曲拉和氮杂胞苷用于初治的伴有过多 blasts 的骨髓增生异常综合征患者的 I/II 期临床试验

2025-10-100
OAAI
Targeting processive transcription for Myc-driven circuitry in medulloblastoma

靶向髓母细胞瘤中Myc驱动的通路进行持续转录

2025-07-011
PRE
Erythroblastic Sarcoma in Adult and Pediatric Populations: different pathways to the same destination
2025-03-010
PRE
Omacetaxine and Azacitidine for Newly Diagnosed Patients with Myelodysplastic Syndromes and Excess Blasts

奥马扎克汀和阿扎胞苷用于新诊断的伴有过多原始细胞的骨髓增生异常综合征患者

BLOOD
IF23.1
2024-11-050
PRE
A multicenter analysis of individuals with a 47,XXY/46,XX karyotype
2024-10-010
PRE
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC

通过母体和MET酪氨酸激酶抑制剂联合治疗转移性癌基因驱动的NSCLC患者获得性MET耐药的疗效和安全性

2024-02-015
OA